Richard Walovitch

Richard Walovitch has a rich work experience spanning several companies and roles. Richard currently serves as the Chief Scientific Officer at VOIANT™ since September 2023. Prior to that, they were the Founder and Principle Consultant at CR Squared since July 2019. Richard also held the position of Chief Scientific Officer at WorldCare Clinical from June 2017 to August 2023. Before that, they served as the Chief Medical Officer at WorldCare Clinical from January 2009 to November 2010. Richard has also worked as the SVP Clinical Research at Acusphere, Inc. from March 1997 to January 2009. Richard served as the VP Clinical Research at EPIX Therapeutics, Inc. from 1993 to 1996 and as an International Project Clinician at DuPont from 1985 to 1993.

Richard Walovitch holds a PhD in Pharmacology from the University of Illinois College of Medicine. The specific start and end years of their education are not provided.